---
title: "Protagenic Therapeutics executive chair Garo H. Armen buys 2,220 shares for $710.4"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295718074.md"
description: "Garo H. Armen, Executive Chair and Principal Officer of Protagenic Therapeutics, purchased 2,220 common shares at $0.32 each, totaling $710.40. This transaction increased his directly held common stock position to 34,199 shares. The disclosure was filed via EDGAR on August 12, 2026."
datetime: "2026-08-12T22:52:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295718074.md)
  - [en](https://longbridge.com/en/news/295718074.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295718074.md)
generator: "portal-rs"
---

# Protagenic Therapeutics executive chair Garo H. Armen buys 2,220 shares for $710.4

-   Protagenic Therapeutics Executive Chair and Principal Officer Garo H. Armen bought 2,220 common shares at USD 0.32 each. \* Directly held common stock position rose to 34,199 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagenic Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037468), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [PTIX.US](https://longbridge.com/en/quote/PTIX.US.md)
- [PTIXW.US](https://longbridge.com/en/quote/PTIXW.US.md)

## Related News & Research

- [Protagenic Therapeutics executive chair Garo H. Armen acquires 20,000 common shares for $13,000](https://longbridge.com/en/news/296815833.md)
- [Protagenic Therapeutics executive chair Garo H. Armen acquires 2,700 common shares for $945](https://longbridge.com/en/news/296498804.md)
- [Renewi backs Dutch taskforce action agenda for fully circular electronics supply chain by 2050](https://longbridge.com/en/news/298002754.md)
- [Bel Fuse director Vincent Vellucci disposes of 393 common shares worth $95,738.73](https://longbridge.com/en/news/298055432.md)
- [Protagenic Therapeutics exec chair Garo H. Armen acquires 685 common shares worth $150.7](https://longbridge.com/en/news/295420860.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**